Sacheerome Ltd
Incorporated in 2009, Sacheerome Ltd is in
the business of designing & manufacturing fragrance and flavours[1]
- Market Cap ₹ 827 Cr.
- Current Price ₹ 370
- High / Low ₹ 553 / 249
- Stock P/E 27.3
- Book Value ₹ 73.8
- Dividend Yield 0.00 %
- ROCE 35.7 %
- ROE 27.0 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 27.5%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Part of Nifty SME Emerge
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| 64 | 70 | 85 | 108 | 152 | 160 | |
| Sales growth | +10% | +21% | +26% | +42% | +20% | |
| 55 | 61 | 70 | 85 | 116 | 121 | |
| Operating Profit | 9 | 10 | 15 | 22 | 37 | 40 |
| OPM % | 13% | 14% | 18% | 21% | 24% | 25% |
| 0 | 0 | 1 | 1 | 4 | 4 | |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 3 |
| Profit before tax | 6 | 8 | 15 | 21 | 38 | 41 |
| Tax % | 27% | 28% | 27% | 25% | 25% | |
| 5 | 6 | 11 | 16 | 28 | 30 | |
| EPS in Rs | 2.79 | 3.67 | 6.50 | 9.78 | 12.71 | 13.53 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 29% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 68% |
| TTM: | 27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 20% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 28% |
| Last Year: | 27% |
Balance Sheet
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 16 | 16 | 22 | 22 |
| Reserves | 25 | 31 | 30 | 46 | 126 | 143 |
| 8 | 0 | 1 | 3 | 0 | 0 | |
| 11 | 14 | 16 | 19 | 24 | 34 | |
| Total Liabilities | 49 | 49 | 64 | 84 | 172 | 199 |
| 9 | 21 | 22 | 23 | 24 | 22 | |
| CWIP | 0 | 2 | 8 | 28 | 57 | 88 |
| Investments | 0 | 0 | 0 | 0 | 0 | 1 |
| 40 | 27 | 33 | 33 | 90 | 87 | |
| Total Assets | 49 | 49 | 64 | 84 | 172 | 199 |
Cash Flows
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 9 | 11 | 10 | 22 | 26 | |
| -4 | -2 | -10 | -23 | -79 | |
| -6 | -9 | 1 | 2 | 54 | |
| Net Cash Flow | -1 | 0 | 1 | 1 | 2 |
| Free Cash Flow | 6 | 9 | 0 | -2 | -14 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 141% | 128% | 91% | 127% | 98% |
Ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 67 | 63 | 68 | 52 | 47 |
| Inventory Days | 113 | 100 | 85 | 61 | 47 |
| Days Payable | 71 | 73 | 73 | 81 | 61 |
| Cash Conversion Cycle | 109 | 89 | 80 | 33 | 33 |
| Working Capital Days | 37 | 63 | 58 | 24 | 31 |
| ROCE % | 24% | 36% | 38% | 36% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Capacity Utilization % |
|
|||
| Export Sales Share % |
||||
| Fragrance Revenue Share % |
||||
| Installed Annual Capacity kg |
||||
| Production Volume kg |
||||
| Top 5 Customer Revenue Share % |
||||
| R&D Specialists specialists |
||||
| Total Team Strength employees |
||||
Extracted by Screener AI
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
- H1 FY27 transcript: YEIDA facility trial production began in September; commercial start awaits final statutory certificates.
-
Monitoring Agency Report
- CRISIL issued monitoring agency report for quarter ended September 30, 2026 on IPO proceeds utilization.
-
Analysts/Institutional Investor Meet/Con. Call Updates
- Audio recording of 4 November 2026 earnings conference call uploaded; transcript to follow.
-
Investor Presentation
- Sacheerome reports H1 FY27 income of ₹85.92 crore; YEIDA facility trial production began in September 2026.
-
Copy of Newspaper Publication
- Announcement text is garbled and no clear event can be identified.
Concalls
-
Nov 2026Transcript REC
-
Sep 2026PPT
-
Jun 2026Transcript PPT
-
Dec 2025Transcript PPT
-
Aug 2025PPT
Business Overview:[1]
Sacheerome specializes in creation
and manufacturing of Fragrances
& Flavours, which play a crucial
role in customer buying decisions
and preference in the perception
of food and non-food FMCG
products